PsychoGenics, AstraZeneca To Identify New Treatments For CNS
Published: 31-Aug-2009
PsychoGenics' proprietary drug discovery technologies will evaluate a number of AstraZeneca drug candidates
PsychoGenics and AstraZeneca have entered into a drug discovery and development agreement to identify compounds that are likely to be useful for the treatment of certain Central Nervous System (CNS) disorders.
Under the agreement, PsychoGenics will use its proprietary drug discovery technologies to evaluate a number of AstraZeneca drug candidates for their potential to treat psychiatric disorders.
Reportedly, PsychoGenics will receive research payments and milestones commensurate with the stage of development, as well as royalties on any future sales.
Emer Leahy, president and CEO of PsychoGenics, said: We are excited about this collaboration and look forward to working with AstraZeneca’s scientific team. We are confident that, with AstraZeneca’s compound libraries and expertise in CNS drug discovery and our proprietary drug discovery approach, we have an opportunity to identify novel and improved treatments for serious psychiatric disorders.”
Delicious
Digg
Reddit
Stumble
Facebook
LinkedInNetwork Sites
Mail sent successfully
Suppliers To This Sector
Browse A-Z
White Papers
Browse A-Z
Your IP at Risk in Collaborations!
Free white paper: Ten steps to protect your R&D investment within partnerships. ...
Why, When and How to Conduct 14C Human Studies
Several risk-based strategies to assess metabolites exist. Whatever the strategy chosen, t ...
Why CAPA Still Matters
This free white paper explores the needs and effectiveness of correct CAPA control, how to ...
Water Treatment
From the control room to the downstream processing area and with an eye on utilities servi ...
Using the Mean Kinetic Temperature (MKT) As a Parameter to Determine Whether Perishable Goods Have Been Transported and Stored Correctly
Tecnosoft systems use MKT calculation to control the acquired values and report the user w ...
USB HotStart-IT for Real Time PCR
USB® Products from Affymetrix have a long-standing reputation in the life science marketpl ...
